Publication | Closed Access

Immunoreactive 15-hydroxyprostaglandin dehydrogenase (PGDH) is reduced in fetal membranes from patients at preterm delivery in the presence of infection

Maternal ImmunizationEmbryologyPreterm DeliveryImmunologyFetal MedicineGynecologyPregnancyMaternal HealthImmunoreactive 15-Hydroxyprostaglandin DehydrogenaseMaternal-fetal MedicinePublic HealthFetal ComplicationMedicineFetal MembranesPlacental Development